Insights Advancing the Future of Pharmaceuticals

Equinox Group specializes in assessing the commercial potential of drug programs in all stages of R&D, delivering quantitative insights in disease area strategy, market access, patient share forecasting, patient flow, and epidemiology.

0+
Years Of Experience
0+
Drug Assessments

Areas of Expertise

Disease - Area Strategy

Find out which indications offer the best commercial opportunities and how to prioritize them

Business Development & Early R&D

Assess an asset's commercial potential, whether you're evaluating an in-licensing opportunity or developing a TPP

Late-Stage Development

Dive into our patient-share forecasting, patient-flow modeling, and market access tools

Discover the framework at the heart of our analysis and how we use it to predict patient share

The Unmet Need Framework

Recent Articles

Want to get in touch?

Click here